These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

367 related items for PubMed ID: 12843054

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Mechanisms of decreased susceptibility to cefpodoxime in Escherichia coli.
    Oliver A, Weigel LM, Rasheed JK, McGowan JE, Raney P, Tenover FC.
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3829-36. PubMed ID: 12435684
    [Abstract] [Full Text] [Related]

  • 4. Utility of NCCLS guidelines for identifying extended-spectrum beta-lactamases in non-Escherichia coli and Non-Klebsiella spp. of Enterobacteriaceae.
    Schwaber MJ, Raney PM, Rasheed JK, Biddle JW, Williams P, McGowan JE, Tenover FC.
    J Clin Microbiol; 2004 Jan; 42(1):294-8. PubMed ID: 14715768
    [Abstract] [Full Text] [Related]

  • 5. Effects of inoculum and beta-lactamase activity in AmpC- and extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli and Klebsiella pneumoniae clinical isolates tested by using NCCLS ESBL methodology.
    Queenan AM, Foleno B, Gownley C, Wira E, Bush K.
    J Clin Microbiol; 2004 Jan; 42(1):269-75. PubMed ID: 14715764
    [Abstract] [Full Text] [Related]

  • 6. Cephalosporin MIC distribution of extended-spectrum-{beta}-lactamase- and pAmpC-producing Escherichia coli and Klebsiella species.
    Kohner PC, Robberts FJ, Cockerill FR, Patel R.
    J Clin Microbiol; 2009 Aug; 47(8):2419-25. PubMed ID: 19494061
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Evaluation of the current National Committee for Clinical Laboratory Standards guidelines for screening and confirming extended-spectrum beta-lactamase production in isolates of Escherichia coli and Klebsiella species from bacteremic patients.
    Katz OT, Peled N, Yagupsky P.
    Eur J Clin Microbiol Infect Dis; 2004 Nov; 23(11):813-7. PubMed ID: 15480883
    [Abstract] [Full Text] [Related]

  • 11. Comparison of screening methods for TEM- and SHV-derived extended-spectrum beta-lactamase detection.
    MacKenzie FM, Miller CA, Gould IM.
    Clin Microbiol Infect; 2002 Nov; 8(11):715-24. PubMed ID: 12445009
    [Abstract] [Full Text] [Related]

  • 12. Characterization of clinical isolates of Enterobacteriaceae from Italy by the BD Phoenix extended-spectrum beta-lactamase detection method.
    Sanguinetti M, Posteraro B, Spanu T, Ciccaglione D, Romano L, Fiori B, Nicoletti G, Zanetti S, Fadda G.
    J Clin Microbiol; 2003 Apr; 41(4):1463-8. PubMed ID: 12682131
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Comparison of screening methods for detection of extended-spectrum beta-lactamases and their prevalence among blood isolates of Escherichia coli and Klebsiella spp. in a Belgian teaching hospital.
    Vercauteren E, Descheemaeker P, Ieven M, Sanders CC, Goossens H.
    J Clin Microbiol; 1997 Sep; 35(9):2191-7. PubMed ID: 9276386
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Use of the cefepime-clavulanate ESBL Etest for detection of extended-spectrum beta-lactamases in AmpC co-producing bacteria.
    Mohanty S, Gaind R, Ranjan R, Deb M.
    J Infect Dev Ctries; 2009 Nov 21; 4(1):24-9. PubMed ID: 20130375
    [Abstract] [Full Text] [Related]

  • 17. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S, Haldorsen B, Dahl KH, Simonsen GS, Steinbakk M, Walsh TR, Sundsfjord A, Norwegian ESBL Study Group.
    J Clin Microbiol; 2007 Jan 21; 45(1):199-205. PubMed ID: 17079502
    [Abstract] [Full Text] [Related]

  • 18. Patterns and mechanisms of resistance to beta-lactams and beta-lactamase inhibitors in uropathogenic Escherichia coli isolated from dogs in Portugal.
    Féria C, Ferreira E, Correia JD, Gonçalves J, Caniça M.
    J Antimicrob Chemother; 2002 Jan 21; 49(1):77-85. PubMed ID: 11751770
    [Abstract] [Full Text] [Related]

  • 19. A nationwide study of mechanisms conferring reduced susceptibility to extended-spectrum cephalosporins in clinical Escherichia coli and Klebsiella spp. isolates.
    Tofteland S, Dahl KH, Aasnæs B, Sundsfjord A, Naseer U.
    Scand J Infect Dis; 2012 Dec 21; 44(12):927-33. PubMed ID: 22991975
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.